Adverse events158

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 158

Type	Event	Organ system	Group	Affected	At risk
other	Cytomegalovirus infection	Infections and infestations	Rivogenlecleucel (BPX-501) Safety Population	34	171
other	Cytomegalovirus infection	Infections and infestations	Rimiducid Safety Population	0	16
other	Adenovirus infection	Infections and infestations	Rivogenlecleucel (BPX-501) Safety Population	11	171
other	Adenovirus infection	Infections and infestations	Rimiducid Safety Population	0	16
other	Human herpesvirus 6 infection	Infections and infestations	Rivogenlecleucel (BPX-501) Safety Population	9	171
other	Human herpesvirus 6 infection	Infections and infestations	Rimiducid Safety Population	0	16
other	Acute graft versus host disease	Immune system disorders	Rivogenlecleucel (BPX-501) Safety Population	48	171
other	Acute graft versus host disease	Immune system disorders	Rimiducid Safety Population	3	16
other	Rash	Skin and subcutaneous tissue disorders	Rivogenlecleucel (BPX-501) Safety Population	21	171
other	Rash	Skin and subcutaneous tissue disorders	Rimiducid Safety Population	0	16
other	Pruritus	Skin and subcutaneous tissue disorders	Rivogenlecleucel (BPX-501) Safety Population	12	171
other	Pruritus	Skin and subcutaneous tissue disorders	Rimiducid Safety Population	0	16
other	Diarrhea	Gastrointestinal disorders	Rivogenlecleucel (BPX-501) Safety Population	20	171
other	Diarrhea	Gastrointestinal disorders	Rimiducid Safety Population	0	16
other	Vomiting	Gastrointestinal disorders	Rivogenlecleucel (BPX-501) Safety Population	20	171
other	Vomiting	Gastrointestinal disorders	Rimiducid Safety Population	0	16
other	Nausea	Gastrointestinal disorders	Rivogenlecleucel (BPX-501) Safety Population	10	171
other	Nausea	Gastrointestinal disorders	Rimiducid Safety Population	0	16
other	Pyrexia	General disorders	Rivogenlecleucel (BPX-501) Safety Population	33	171
other	Pyrexia	General disorders	Rimiducid Safety Population	0	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03733249/events

API reference For AI assistants

Adverse events158

Sources 3

Read this list from software.